高尿酸血症对急性心肌梗死发病和预后的影响研究进展

doi:10.3969/j.issn.1006-5725.2024.05.023

Abstract

Abstract:

Acute myocardial infarction （AMI） is one of the leading causes of cardiac death. The percutaneous coronary intervention （PCI） can improve the prognosis of AMI patients， but the overall prognosis of AMI patients is not optimistic. Hyperuricemia has become one of the risk factors for cardiovascular diseases. The role of hyperuricemia in the occurrence， development and prognosis of AMI has attracted increasing attention. This article reviews the research progress on the relationship between hyperuricemia and AMI.

Key words: uric acid, hyperuricemia, acute myocardial infarction, percutaneous coronary intervention

CLC Number:

R541.4

Jianlong SHENG,Ni′na. LIU. The advanced progress on the relationship between hyperuricemia and acute myocardial infarction[J]. The Journal of Practical Medicine, 2024, 40(5): 727-730.

References 35

1	ANDERSON J L， MORROW D A. Acute Myocardial Infarction［J］. N Engl J Med， 2017， 376（21）：2053-2064. doi:10.1056/nejmra1606915 doi: 10.1056/nejmra1606915
2	BORGHI C， DOMIENIK-KARŁOWICZ J， TYKARSKI A，et al.Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk： 2021 update［J］. Cardiol J， 2021，28（1）：1-14. doi:10.5603/cj.a2021.0001 doi: 10.5603/cj.a2021.0001
3	TALPUR A S， FATTAH A， HEWADMAL H，et al. Asymptomatic Hyperuricemia as an Independent Risk Factor for Myocardial Infarction in Adult Population： A Four-Year Follow-Up Study［J］. Cureus， 2023，15（2）：e34614.
4	KIM S， HWANG B H， LEE K Y， et al. High Uric Acid Levels in Acute Myocardial Infarction Provide Better Long-Term Prognosis Predictive Power When Combined with Traditional Risk Factors［J］. J Clin Med，2022， 11（19）：5531. doi:10.3390/jcm11195531 doi: 10.3390/jcm11195531
5	HAJIZADEH R， GHAFFARI S， SALEHI R， et al. Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction［J］. J Cardiovasc Thorac Res，2016，8（2）：56-60. doi:10.15171/jcvtr.2016.11 doi: 10.15171/jcvtr.2016.11
6	ALVAREZ-LARIO B， MACARRON-VICENTE J. Uric acid and evolution［J］.Rheumatology， 2010，49（11）：2010-2015. doi:10.1093/rheumatology/keq204 doi: 10.1093/rheumatology/keq204
7	黄叶飞，杨克虎，陈澍洪，等. 高尿酸血症/痛风患者实践指南［J］. 中华内科杂志，2020，59 （7）：519-527. doi:10.3760/cma.j.cn112138-20200505-00449 doi: 10.3760/cma.j.cn112138-20200505-00449
8	SONG P， WANG H， XIA W， et al. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China［J］. Sci Rep，2018，8（1）：4314. doi:10.1038/s41598-018-22570-9 doi: 10.1038/s41598-018-22570-9
9	CHEN-XU M， YOKOSE C， RAI S K， et al. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends： The National Health and Nutrition Examination Survey， 2007-2016［J］. Arthritis Rheumatol， 2019，71（6）：991-999. doi:10.1002/art.40807 doi: 10.1002/art.40807
10	LIU R， HAN C， WU D， et al. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014： A Systematic Review and Meta-Analysis［J］. Biomed Res Int， 2015，2015：762820. doi:10.1155/2015/762820 doi: 10.1155/2015/762820
11	COLANTONIO L D， SAAG K G， SINGH J A， et al. Gout is associated with an increased risk for incident heart failure among older adults： the REasons for Geographic And Racial Differences in Stroke （REGARDS） cohort study［J］. Arthritis Res Ther， 2020，22（1）：86. doi:10.1186/s13075-020-02175-2 doi: 10.1186/s13075-020-02175-2
12	BOARDMAN N T， FALCK A T， LUND T， et al. Human concentrations of uric acid scavenges adaptive and maladaptive reactive oxygen species in isolated rat hearts subjected to ischemic stress［J］. Can J Physiol Pharmacol， 2020，98（3）：139-146. doi:10.1139/cjpp-2019-0024 doi: 10.1139/cjpp-2019-0024
13	ZHOU Z， ZHONG S， LIANG Y， et al. Serum Uric Acid and the Risk of Dementia： A Systematic Review and Meta-Analysis［J］. Front Aging Neurosci， 2021，13：625690. doi:10.3389/fnagi.2021.625690 doi: 10.3389/fnagi.2021.625690
14	HONG Q， WANG L， HUANG Z，et al. High Concentrations of Uric Acid and Angiotensin II Act Additively to Produce Endothelial Injury［J］. Mediators Inflamm， 2020，2020：8387654. doi:10.1155/2020/8387654 doi: 10.1155/2020/8387654
15	TIAN X， ZUO Y， CHEN S， et al. Associations between changes in serum uric acid and the risk of myocardial infarction［J］. Int J Cardiol， 2020，314：25-31. doi:10.1016/j.ijcard.2020.03.083 doi: 10.1016/j.ijcard.2020.03.083
16	KUŹMA Ł， KULIKOWSKA A， KURASZ A， et al. The effect of serum uric acid levels on the long-term prognosis of patients with non-ST-elevation myocardial infarction［J］. Adv Clin Exp Med， 2020，29（11）：1255-1263. doi:10.17219/acem/127145 doi: 10.17219/acem/127145
17	KAYA M G， UYAREL H， AKPEK M， et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention［J］.Am J Cardiol， 2012，109（4）：486-491. doi:10.1016/j.amjcard.2011.09.042 doi: 10.1016/j.amjcard.2011.09.042
18	LAZZERI C， VALENTE S， CHIOSTRI M， et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI： its prognostic role and relation with inflammatory markers： a single center experience［J］. Int J Cardiol， 2010，138（2）：206-209. doi:10.1016/j.ijcard.2008.06.024 doi: 10.1016/j.ijcard.2008.06.024
19	LAZZERI C， VALENTE S， CHIOSTRI M， et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction［J］. Intern Emerg Med， 2012，7（1）：33-39. doi:10.1007/s11739-011-0515-9 doi: 10.1007/s11739-011-0515-9
20	WANG A， TIAN X， WU S， et al. Metabolic Factors Mediate the Association Between Serum Uric Acid to Serum Creatinine Ratio and Cardiovascular Disease［J］. J Am Heart Assoc， 2021，10（23）：e023054. doi:10.1161/jaha.121.023054 doi: 10.1161/jaha.121.023054
21	LIU W， YU W， XIE D， et al. High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy［J］. J Atheroscler Thromb， 2023， 30（9）：1176-1186. doi:10.5551/jat.63645 doi: 10.5551/jat.63645
22	CHENG X， LIU T， MA L， et al.Prothrombotic effects of high uric acid in mice via activation of MEF2C-dependent NF-κB pathway by upregulating let-7c［J］. Aging （Albany NY）， 2020，12（18）：17976-17989. doi:10.18632/aging.103540 doi: 10.18632/aging.103540
23	KOBAYASHI N， HATA N， TSURUMI M， et al. Relation of Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Cardiac Outcomes to Serum Uric Acid Levels in Patients With Acute Coronary Syndrome［J］. Am J Cardiol，2018，122（1）：17-25. doi:10.1016/j.amjcard.2018.03.022 doi: 10.1016/j.amjcard.2018.03.022
24	MANDURINO-MIRIZZI A， CORNARA S， SOMASCHINI A， et al. Elevated serum uric acid is associated with a greater inflammatory response and with short- and longterm mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention［J］. Nutr Metabol Cardiovasc Dis， 2021，31（2）：608-614. doi:10.1016/j.numecd.2020.10.020 doi: 10.1016/j.numecd.2020.10.020
25	MANDURINO-MIRIZZI A， CRIMI G， RAINERI C， et al. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention［J］. J Cardiovasc Med （Hagerstown）， 2018，19（5）：240-246. doi:10.2459/jcm.0000000000000634 doi: 10.2459/jcm.0000000000000634
26	HU X， YANG X， LI X， et al. Elevated uric acid is related to the no-/slow-reflow phenomenon in STEMI undergoing primary PCI［J］. Eur J Clin Invest， 2022，52（4）：e13719. doi:10.1111/eci.13719 doi: 10.1111/eci.13719
27	中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南（2019）［J］. 中华内分泌代谢杂志， 2020，36（1）：1-13
28	MACKENZIE I S， HAWKEY C J， FORD I， et al. Allopurinol versus usual care in UK patients with ischaemic heart disease （ALL-HEART）： a multicentre， prospective， randomised， open-label， blinded-endpoint trial［J］. Lancet， 2022，400（10359）：1195-1205. doi:10.1016/s0140-6736(22)01657-9 doi: 10.1016/s0140-6736(22)01657-9
29	HROMADKA M， OPATRNY J， MIKLIK R， et al. Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk［J］. J Comp Eff Res， 2021，10（12）：979-988. doi:10.2217/cer-2021-0082 doi: 10.2217/cer-2021-0082
30	AL-ABDOUH A， KHAN S U， BARBARAWI M， et al. Effects of Febuxostat on Mortality and Cardiovascular Outcomes： A Systematic Review and Meta-Analysis of Randomized Controlled Trials［J］. Mayo Clin Proc Innov Qual Outcomes， 2020，4（4）：434-442. doi:10.1016/j.mayocpiqo.2020.04.012 doi: 10.1016/j.mayocpiqo.2020.04.012
31	MACKENZIE I S， FORD I， NUKI G， et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout （FAST）： a multicentre， prospective， randomised， open-label， non-inferiority trial［J］. Lancet， 2020，396（10264）：1745-1757. doi:10.1016/s0140-6736(20)32234-0 doi: 10.1016/s0140-6736(20)32234-0
32	逄成章，刘文彬，金小宝. 基于疾病基因表达谱和药物转录组的抗高尿酸血症药物“重定位”［J］. 实用医学杂志， 2022，38（22）：2838-2844.
33	DOEHNER W， ANKER S D， BUTLER J， et al. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction： the EMPEROR-reduced trial［J］. Eur Heart J， 2022，43（36）：3435-3446. doi:10.1093/eurheartj/ehac320 doi: 10.1093/eurheartj/ehac320
34	CASIGLIA E， TIKHONOFF V， VIRDIS A， et al. Serum uric acid and fatal myocardial infarction： detection of prognostic cut-off values： The URRAH （Uric Acid Right for Heart Health） study［J］. J Hypertens， 2020，38（3）：412-419. doi:10.1097/hjh.0000000000002287 doi: 10.1097/hjh.0000000000002287
35	王贤方，刘志东，张园，等. 南方汉族人群ABCG2 rs2231142和SLC2A9 rs3733591单核苷酸多态性与高尿酸血症及心血管危险因素的相关性［J］. 实用医学杂志， 2023，39（7）：875-880.

[1]	Yue REN,Ting TIAN,Guangsheng WEI,Ming ZHANG,Hong YU,Jie LI,Tingting DONG,Yinmei FENG,Hongchao CUI,Jiao. ZHANG. Effect of stage I comprehensive cardiac rehabilitation in patients with acute ST elevation myocardial infarctionafter emergency percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(5): 682-687.
[2]	Kaiyang WANG,Jing TAO,Tingting WU,Jiahui YONG,Guoqing LI,Xiang XIE,Yining. YANG. Correlation of novel anthropometric indicators with long⁃term prognosis in patients with acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(21): 3040-3046.
[3]	Xinhe WANG,Chuangwen YE,Huasheng TONG,Fei MENG,Xiansheng ZHU. The value of noninvasive left ventricular pressure⁃strain loop in evaluating left ventricular function and left ventricular remodeling before and after percutaneous coronary artery intervention in patients with acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(20): 2841-2847.
[4]	Qian ZHAO,Yan ZHANG,Qiao QIAO,Aiyun DENG. Prognostic factors of patients undergoing percutaneous coronary intervention supported by extracorporeal membrane oxygenation [J]. The Journal of Practical Medicine, 2024, 40(2): 219-224.
[5]	Xian WEN,Xianfeng ZENG,Ruiya SU. Efficacy of ivabradine combined with levosimendan in patients with acute myocardial infarction complicated with heart failure [J]. The Journal of Practical Medicine, 2024, 40(2): 242-247.
[6]	Yao ZHANG,Yingxin HUO,Wei ZHAO,Rongjie TANG,Qiufang. LIAN. The relationship between blood uric acid levels and non⁃alcoholic fatty liver disease in patients with type H hypertension [J]. The Journal of Practical Medicine, 2024, 40(18): 2561-2565.
[7]	Shuping GE,Wei CHEN,Xinxin JIA,Min GAO,Min HE,Cunyu. QIN. Effect of individual exercise training as the core cardiac rehabilitation program on the rehabilitation of patients with coronary heart disease after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(18): 2607-2611.
[8]	Guojun CHEN,Tianen ZHOU,Hongfeng LIU,Li′na PENG,Jun JIANG,Chunming. XIE. Diagnostic value of POCT⁃cTnT for acute myocardial infarction based on symptom onset time [J]. The Journal of Practical Medicine, 2024, 40(16): 2326-2332.
[9]	Weifeng ZHANG,Hailong MA,Jinling. ZHANG. Effect of PCSK9 inhibitors on inflammation levels and ventricular remodeling after PCI in ST⁃elevation acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(15): 2142-2147.
[10]	A′fang SU,Guangjian LI,Yunshui ZHANG,Xiujuan ZHAO,Shouling WU,Xiaozhong. JIANG. A study on the association between exposure of uric acid accumulation and risks of acute pancreatitis [J]. The Journal of Practical Medicine, 2024, 40(14): 2009-2014.
[11]	Yuan YANG,Peng HU,Yan. HUANG. Current status of knowledge， attitude and practice of hyperuricemia health management in community medical staff based on mixed methods study [J]. The Journal of Practical Medicine, 2024, 40(14): 2015-2020.
[12]	Yapeng LIANG,Chaopu ZHANG,Hao ZHANG,Zhongqun. WANG. The relationship between the expression of serum ANGPTL8 and KLF2 and the degree of coronary artery disease and the occurrence of major adverse cardiac events in patients with acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(13): 1827-1832.
[13]	Youming ZHANG,Junhui GONG,Hongtao ZHU. Relationship between serum CTRP12 level and in⁃stent restenosis in patients with acute myocardial infarction after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(12): 1671-1676.
[14]	Juan LI,Lin. YANG. Clinical efficacy of Niaoduqing Granule combined with Febusta in treatment of hyperuricemia with renal damage [J]. The Journal of Practical Medicine, 2024, 40(10): 1418-1422.
[15]	WANG Xianfang, LIU Zhidong, ZHANG Yuan, HUANG Changjing, ZHANG Haifei, YU Liqiong, ZHONG Wei.. Association of ABCG2 rs 2231142 and SLC2A9rs 3733591 gene polymorphisms with hyperuricemia in Southern Han population [J]. The Journal of Practical Medicine, 2023, 39(7): 875-880.

The advanced progress on the relationship between hyperuricemia and acute myocardial infarction

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 35

Related Articles 15

Recommended Articles

Metrics

Comments